Question 1

What is Dihexa?

Accepted Answer

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide analog of angiotensin IV developed at Washington State University. It is one of the most potent cognitive-enhancing compounds identified in research, reported to be approximately 10 million times more potent than BDNF at promoting synaptic connectivity.

Question 2

What are the research benefits of Dihexa?

Accepted Answer

Research on Dihexa has investigated its potential effects in several areas, including: Reported 10 million times more potent than BDNF for synaptic connectivity; Orally bioavailable (rare for cognitive peptides); Studied for age-related cognitive decline in animal models; Promotes synaptogenesis and dendritic spine growth. These findings are primarily from preclinical and animal studies unless otherwise noted. Results may not translate directly to humans.

Question 3

How does Dihexa work?

Accepted Answer

Dihexa acts as a potent agonist of the hepatocyte growth factor (HGF) / c-Met receptor system in the brain. Activation of c-Met signaling promotes synaptogenesis (formation of new synaptic connections), dendritic spine growth, and neuronal survival. This mechanism is distinct from and potentially complementary to other neurotrophic pathways (BDNF, NGF).

Question 4

What is the FDA/legal status of Dihexa?

Accepted Answer

Dihexa is not currently FDA-approved for human therapeutic use. It is classified as a research compound and is available for research use only. It has not been evaluated for safety or efficacy in humans by regulatory agencies. Always consult applicable laws in your jurisdiction before purchase or use.

Question 5

What are the known risks or side effects of Dihexa?

Accepted Answer

Based on available research, Dihexa has been associated with the following in study settings: Very limited safety data (primarily animal research); Potential oncogenic concerns (HGF/c-Met pathway involved in cancer); Long-term effects unknown; No human clinical trials completed. Long-term safety data in humans is limited or absent for most research peptides. This should not be taken as a complete safety profile.

Question 6

Where can I find published research on Dihexa?

Accepted Answer

Published research on Dihexa can be found on PubMed (pubmed.ncbi.nlm.nih.gov). Search for "Dihexa" or its aliases (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) to find peer-reviewed studies. PEP.WIKI aggregates key studies with abstracts and study type classifications on each compound's research page.

Dihexa

Overview

Mechanism of Action

Key Research Benefits

Clinical Evidence Summary

Key Studies / PubMed References

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.

Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy.

Stem cell, Granulocyte-Colony Stimulating Factor and/or Dihexa to promote limb function recovery in a rat sciatic nerve damage-repair model: Experimental animal studies.

AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.

Side Effects & Safety

Known Interactions

Frequently Asked Questions

Research Disclaimer